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INTRODUCTION
T-cell development occurs in the thymus and depends on a diverse
array of functionally distinct epithelial cell types within the thymic
stroma. These thymic epithelial cell (TEC) types originate from the
endoderm of the third (and in some species fourth) pharyngeal
pouches (PPs), transient bilateral endodermal structures that
generate both the thymus and parathyroid glands (Le Douarin and
Jotereau, 1975; Gordon et al., 2004). The molecular and cellular
processes that govern thymus organogenesis are best understood in
the mouse (Blackburn and Manley, 2004; Manley and Condie,
2010). By contrast, knowledge of human thymic organogenesis is
based primarily on histological studies, with molecular insight
currently limited to analysis of genetic abnormalities affecting
thymus development; principally, DiGeorge Syndrome, the human
nude syndrome and APECED, which are caused by mutations in
TBX1, FOXN1 and AIRE, respectively (Frank et al., 1999; Baldini,
2005; Villaseñor et al., 2005).
The human thymus is thought to develop from either the third PP
(Norris, 1938) or from both the third and fourth PP (Van Dyke,
1941). As in the mouse, the bilateral human primordia initially each
comprise thymic and parathyroid domains, and are encased in a
neural crest-derived mesenchymal capsule from early in
development. From week 7 [Carnegie stage (CS) 18-19] to mid-
week 8 (CS20-21) of gestation the thymic component of this
primordium migrates ventrally, such that the leading tip of the
migrating thymic rudiment remains attached to the parathyroid by
a thin, elongated, highly lobulated, cord-like structure. This
structure then resolves, separating the parathyroid and thymic
primordia (Norris, 1938), and the two thymic primordia meet and
attach at the pericardium by mid-week 8 (Norris, 1938). It is well
documented that an accessory thymus can exist in the cervical
region in humans (Norris, 1938; Van Dyke, 1941) and, similarly,
the occurrence of cervical thymi in the mouse has recently been
reported (Dooley et al., 2006; Terszowski et al., 2006).
The early human thymic primordium is proposed to contain
undifferentiated epithelial cells, as reported for the mouse (Lampert
and Ritter, 1988; Bennett et al., 2002; Rossi et al., 2006). Medullary
development has been observed from week 8 and distinct cortical
and medullary compartments by week 16. The presence of other
intrathymic cell types, including mesenchymal, vascular and
lymphoid cells, has been reported from mid-week 8 (Haynes et al.,
1984; Haynes and Heinly, 1995). Between 14 and 16 weeks, mature
lymphocytes begin to leave the thymus to seed the peripheral
immune system (Van Dyke, 1941; Lobach and Haynes, 1987).
However, although the morphological events in human thymus
organogenesis are well documented and some information exists
regarding TEC differentiation, molecular regulation of these
processes remains poorly understood. In particular, only very
limited information exists regarding the extent to which
mechanisms known to govern thymus development and function in
the mouse are conserved in human. Furthermore, neither the time of
onset of TEC differentiation nor the identity of markers defining
thymic epithelial progenitor cells (TEPCs) has been determined in
the human fetal thymus. Similarly, neither the timing of initial
hematopoietic colonization nor the identity of the colonizing cells
has been reported. Improved understanding is urgently required,
owing to the clinical need for improved strategies for enhancing or
replacing thymus function in patients (Wils and Cornelissen, 2005;
Lynch et al., 2009; Awong et al., 2010).
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SUMMARY
The thymus is the central site of T-cell development and thus is of fundamental importance to the immune system, but little
information exists regarding molecular regulation of thymus development in humans. Here we demonstrate, via spatial and temporal
expression analyses, that the genetic mechanisms known to regulate mouse thymus organogenesis are conserved in humans. In
addition, we provide molecular evidence that the human thymic epithelium derives solely from the third pharyngeal pouch, as in the
mouse, in contrast to previous suggestions. Finally, we define the timing of onset of hematopoietic cell colonization and epithelial
cell differentiation in the human thymic primordium, showing, unexpectedly, that the first colonizing hematopoietic cells are
CD45+CD34int/–. Collectively, our data provide essential information for translation of principles established in the mouse to the
human, and are of particular relevance to development of improved strategies for enhancing immune reconstitution in patients.
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Here, we demonstrate that the major mechanisms currently known
to underpin thymus organogenesis are conserved between mouse and
human. We further define the age at which overt TEC differentiation
is initiated in human fetal thymus, and establish the timing of
expression of known mediators of TEC function, including the
autoimmune regulator AIRE and the chemokines CCL21 and CCL25.
These observations delineate the stage in thymus development at
which the thymus is composed principally of undifferentiated thymic
epithelial progenitor cells. Finally, we determine the stage of thymus
organogenesis at which colonization by hematopoietic, endothelial
and mesenchymal cells first occurs, identifying the first colonizing
hematopoietic cells as CD45+CD7–CD34lo/– and the first thymus-
seeding T-lineage progenitors as CD45+CD7+CD34int cells, in
contrast to expectations from previous studies (Haddad et al., 2006).
These data, to our knowledge, constitute the first detailed analysis of
human thymus organogenesis and TEC development that is not based
solely on morphological and histological data, and thus provide
essential information for the translation of principles established in
the mouse to the human.
MATERIALS AND METHODS
Human tissue
First and second trimester human fetuses were obtained following elective
medical termination of pregnancy, and all were morphologically normal.
Ethical approval for use of human fetal tissue in these studies was granted
by the Lothian Research Ethics Committee or the Ethics Committee of the
Erasmus University Medical Center. Consent was obtained from all women
in writing, and the tissue was anonymized before being made available for
research. All experiments using human tissue were performed at the
University of Edinburgh or the Erasmus University Medical Center.
Embryos were aged according to the standard head/rump measurement and
Carnegie stage was determined (Gasser, 1975; O’Rahilly and Muller, 1987).
Embryos used in this study were from mid- to late week 6 (CS17), week 7
(CS18-19), early to mid-week 8 (CS20-21), and weeks 9, 10, 15-16 and 17,
with days/weeks indicating days/weeks post-fertilization. Note that
Carnegie staging does not apply to second trimester fetuses.
In situ hybridization
Whole-mount in situ hybridizations were performed as previously described
(Gordon et al., 2001). Probes were made by PCR amplification from human
fetal tissue using primers as listed in supplementary material Table S1.
Immunohistochemistry
Immunohistochemistry was performed as previously described (Gordon et
al., 2004). Primary antibodies used were: anti-cytokeratin (rabbit polyclonal
anti-keratin, Dako); anti-CLDN4 (3E2C1, Zymed); anti-human CD45
(clone HI30, BD Pharmingen); anti-keratin 5 (AF138 rabbit IgG, Covance);
anti-keratin 8 (CAM 5.2, Becton Dickinson); anti-keratin 14 (AF64,
Covance); TE7 (Developmental Studies Hybridoma Bank); UEA1
(biotinylated, Vector Labs); anti-AIRE (D-17, Santa Cruz); anti-CD205
(MG38, Serotec); CDR2 (provided by B. Kyewski, German Cancer
Research Center, Heidelberg, Germany); anti-HLA-DR/DP/DQ (clone
TU39, BD Pharmingen); anti-EPCAM (Ber-EP4, DakoCytomation); anti-
CCL21 (anti-6Ckine, R&D Systems); anti-CCL25/TECK (R&D Systems);
mouse anti-CD11b/Mac1 (ICRF44, BD Pharmingen); mouse anti-CD31
(WM59, BD Pharmingen); mouse anti-CD144 PE (16B1, eBiosciences);
mouse anti-CD34 FITC (581, BD Pharmingen); mouse anti-CD7 (M-T701,
BD Pharmingen). Unconjugated antibodies were detected using goat anti-
mouse Alexa488, goat anti-rabbit Alexa647, goat anti-rat Alexa488, chicken
anti-goat Alexa488, chicken anti-rabbit Alexa594, donkey anti-goat IgG
Alexa488, streptavidin-Alexa647 (all Invitrogen). Appropriate isotype-
control antibodies (BD Pharmingen) provided negative controls in all
experiments. DAPI was used as a nuclear counterstain.
Microscopy
Thymic tissue was microdissected from embryos using an Olympus SZH
dissecting microscope. Images were captured using a ZEISS Stemi SVII
stereomicroscope, an Olympus BX61 stereomicroscope, a Leica AOBS
confocal microscope or a Leica DMRXA microscope under the appropriate
excitation conditions, and were processed using Adobe Photoshop CS4.
Flow cytometry
Thymic single cell suspensions were generated by using enzymatic
dissociation as described for mouse fetal thymus (Nowell et al., 2011) or by
mincing thymic fragments through a 100-µm filter (BD). Flow cytometric
analysis was performed on a LSRII Flow Cytometer (BD) and analyzed
using FlowJo software (Tree Star). Antibodies used were: mouse anti-CD19
DY590 (Exbio Praha), mouse anti-BDCA2 APC (Miltenyi Biotech), rat
anti-CD7 (MCA344, Serotec), mouse anti-human CD45 (clone HI30),
mouse anti-human CD34 FITC (clone 581), mouse anti-CD3 Alexa700,
mouse anti-CD45 PerCP-Cy5, mouse anti-HLA-DR APC-Cy7, mouse anti-
CD123 PE (all BD Pharmingen). Unconjugated antibodies were detected
with goat anti-mouse Alexa647 and goat anti-mouse Alexa 568 (Invitrogen).
Grafted re-aggregate fetal thymic organ culture
Two human thymic lobes (early week 8) were lightly dissociated as
described, mixed with 150,000 mouse primary embryonic fibroblasts and
re-aggregated as described previously (Sheridan et al., 2009). The re-
aggregates were cultured on a filter for 24 hours and then grafted under the
kidney capsule of NOD/SCID recipient mice the next morning. Grafts were
recovered after 2 weeks for analysis.
Affymetrix microarray analysis
RNA was prepared from three independent mid-week 8 thymic lobes
microdissected free of any other cells or tissues (CB094, CS20; CB388,
CS21/22; CB106, CS22). Note that the name of each sample includes both
an identifier (e.g. CB094) and the Carnegie stage of that sample (e.g. CS20).
Samples were amplified, labeled and hybridized to Affymetrix Human
Genome U133Plus2 GeneChip arrays according to standard Affymetrix
protocols. The microarray data were normalized independently using RMA
(Irizarry et al., 2003) and Micro Analysis Suite 5.0 (MAS5) (Liu et al.,
2002), and the probe sets were then ranked based on the resulting expression
values, with the probe set having the highest expression given rank-1. The
data are deposited in the Stem Cell Database under accession number
StemDB-2316 (http://www.stemdb.org/stemdb/utils/show?id=StemDB-
2316). The data presented show ranks for selected probe sets along with the
corresponding MAS5 PMA flag [present (P), marginal (M) and absent (A)].
For a given probe set, the lower the rank the higher the probability of the
gene being present in the sample, whereas MAS5 predicts the presence or
absence of a gene using different statistics. Data were analyzed using
Limma and Affymetrix Bioconductor packages and visualized using
Genespring GX (Agilent).
RESULTS
Spatial and temporal expression of essential
regulators of mouse thymus organogenesis is
conserved in human thymus development
To determine whether molecular mechanisms that regulate thymus
development are conserved between mouse and human, we
investigated the detailed spatial and temporal expression profiles of
known regulators of mouse thymus organogenesis in human
embryos. We first confirmed the relative staging of human and
mouse thymus development. The earliest human tissue available for
this study was early week 6 (CS16). At this stage, the third PP had
formed and morphological criteria indicated that third PP/thymic
primordium development was at an equivalent stage to that at
embryonic day (E)10.5 in CBAxC57BL/6 F1 mouse embryos. By
early week 7 (CS18), outgrowth of the third PP to form the common
thymus/parathyroid primordium (Gordon et al., 2001) had occurred,
equivalent to ~E11.5 in the mouse (Fig. 1A). Migration of the
thymus component of the primordium along the carotid artery was
observed by mid-week 8 (CS21), as described, and at this and
subsequent stages the thymic primordium was surrounded by a
RESEARCH ARTICLE Development 140 (9)
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mesenchymal capsule (Fig. 1B-B). By week 10, the thymic
primordium comprised numerous lobules (Fig. 1C,C; note that the
mid-week 8 thymus is not lobulated), and lobules could also be seen
within the elongated cord connecting the thymus and parathyroid
primordia (Fig. 1C,C). Of note is that from week 8, the
mesenchyme surrounding the human thymic primordium was less
closely associated with the primordium than is the mesenchymal
capsule in the mouse (Fig. 1C, arrow).
We then investigated the expression pattern in week 6 human
embryos of TBX1, HOXA3, PAX1 and PAX9 genes, which encode
proteins with genetically defined roles in patterning of the
pharyngeal endoderm (PE) and/or formation of the third PP. Tbx1 is
required for development of the mouse foregut endoderm, where it
regulates segmentation of the PE and PP patterning (Xu et al., 2005).
Conserved stage-specificity and localization of TBX1 expression
between mouse and human embryos was demonstrated (ISH;
Fig. 2A,A). In the early week 6 (CS16) human embryo, TBX1
expression was detected in the core mesenchyme of the first, second
and third pharyngeal arches (PAs) and in the third PP endoderm
(Fig. 2A,A). Expression was also detected in the epithelium of the
caudal half of the otic vesicle (Fig. 2A).
Hoxa3 is expressed in the mouse from E9.5 in the third
pharyngeal cleft ectoderm, in the third and fourth PA neural crest
cells, and in the third PP endoderm, and is required for thymus and
parathyroid formation (Chisaka and Capecchi, 1991; Manley and
Capecchi, 1995). HOXA3 expression was also conserved between
mouse and human; the anterior boundary of HOXA3 expression in
the week 6 (CS16-17) human embryo was the third PA and, as in the
E10.5 mouse embryo, expression was observed throughout the third
PP and surrounding mesenchyme (Fig. 2B,B).
In the mouse, both Pax1 and Pax9 are expressed in the foregut
endoderm from E8.5 (Neubüser et al., 1995; Wallin et al., 1996) and
are then expressed in all four PPs and in the thymus throughout
organogenesis, becoming restricted to subpopulations of TECs
2017RESEARCH ARTICLEHuman thymus development
Fig. 1. Morphological features of early human thymus development. (A-C) Images show microdissected human fetal thymic primordia at the ages
shown, except for B, which shows anatomical details of the exposed chest cavity to indicate relative locations of thymic primordia, carotid artery and
heart. B shows detail from lower part of thymic primordium (i.e. the leading edge during migration). Arrowheads indicate thymic primordial; white
arrow in C indicates mesenchymal capsule. Images are representative of at least two independent analyses. H, heart; Th, thymus; Wk, week.
Fig. 2. Expression profile of known regulators
of mouse thymus organogenesis in human
thymus development. Images show whole or
sectioned human embryos or microdissected
thymic primordia after in situ hybridization with
the probes indicated. Ages of embryos or
dissected thymus lobes are as shown. 
(A-D) TBX1, HOXA3 and PAX1 images show side
view of whole embryos (top) and coronal
sections (bottom). PAX9 images show side view of
whole embryo; lower panel shows detail of upper
panel. (E,E) FOXN1 images showing ventral view
of whole embryos. (F-F) P63 images showing
side view of whole embryos (left and middle) and
dissected thymic lobe. (G-H) BMP4 and BMP2
images showing side view of whole embryos. 
(I) CLDN4 image showing dissected thymic lobe.
Images are representative of at least two
independent analyses. PP1, first PP; PP2, second
PP; PP3, third PP; PP4, fourth PP; Th, thymus; Wk,
week.
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postnatally (Neubüser et al., 1995; Wallin et al., 1996). Here, PAX1
expression was investigated in a week 6 human embryo; expression
was observed in all four PPs (Fig. 2C,C). PAX9 expression was
also examined in human embryos at week 6; expression was evident
in the third and fourth PPs but was not detected in the first and
second pouches (Fig. 2D,D). Thus, whereas the expression pattern
of PAX1 is conserved between mouse and human, PAX9 expression
in the human PE is more restricted than in the mouse at the
equivalent developmental stage.
Foxn1 is required cell-autonomously for development of mouse
TECs but is not required for initiation of thymus organogenesis
(Blackburn et al., 1996; Nehls et al., 1996; Nowell et al., 2011). Null
mutations in Foxn1 result in athymia and hairlessness in mice, rats
and humans (Flanagan, 1966; Festing et al., 1978; Nehls et al., 1994;
Frank et al., 1999). In the mouse, Foxn1 expression initiates at the
ventral tip of the third PP at E11.25 (in CBAxC57BL/6 embryos)
and spreads to the entire thymus domain by E11.5 (Gordon et al.,
2001). We could not detect FOXN1 expression in the third PP of
early week 6 (CS16) human embryos (not shown) but observed
strong expression throughout the thymus domain of the third PP by
mid-week 6 (CS16-17; Fig. 2E), suggesting that timing of initiation
of high-level FOXN1 expression occurs at equivalent developmental
stages in human and mouse. FOXN1 expression was also seen
throughout the thymic lobes at week 8 (CS20-21; Fig. 2E). The
human thymus has been suggested to develop from both the third
and fourth PPs (Norris, 1938; Van Dyke, 1941). However, we did
not detect FOXN1 expression in the fourth PP at any stage of
development (Fig. 2E,E). This establishes that in the human, as in
the mouse, the thymus arises solely from the third PP, indicating
that the mechanisms of early thymus organogenesis are closely
conserved between these species. Of note is that GCM2, which
delineates the parathyroid domain within the pouch, is expressed in
both the third and fourth PPs in human (Liu et al., 2010), in keeping
with the proposition that human parathyroids derive from both the
third and fourth PPs.
We also determined the expression pattern of P63 (TP63 –
Human Gene Nomenclature Database), because in the mouse p63
(Trp63 – Mouse Genome Informatics) has a pivotal role in many
stratified epithelia, including the thymus (Candi et al., 2007; Senoo
et al., 2007). In the early week 6 (CS16-17) human embryo, P63
was expressed by the ectoderm surrounding the pharyngeal arches
(Fig. 2F), consistent with its expression in the pharyngeal ectoderm
in the mouse from E9.5 (Mills et al., 1999). By mid-week 6, P63
expression was observed in the endoderm of the third PP (Fig. 2F)
and by late week 8, it appeared to be expressed by all TECs
(Fig. 2F). Thus, P63 expression in the pharyngeal region is also
conserved between mouse and human.
Finally, we analyzed the expression of BMP2 and BMP4, because
BMP signaling has been implicated both in thymus development
(Gordon et al., 2010) and as a possible regulator of Foxn1 (Tsai et
al., 2003; Senoo et al., 2007). BMP4 expression was observed in
the second and third PP endoderm and adjacent mesenchyme in the
mid-week 6 (CS16-17) human embryo (Fig. 2G,G), consistent with
its expression pattern at E10.5 in the mouse (Patel et al., 2006),
whereas BMP2 was expressed in the third and fourth PP endoderm
of the early week 6 (CS16) embryo (Fig. 2H), as observed in the
mouse from E9.5 (Lyons et al., 1990).
Collectively, these data demonstrate that the spatial and temporal
expression of transcription factors and signaling molecules involved
in mouse thymus organogenesis is highly conserved in human
thymus development, albeit with some minor regional differences.
This strongly suggests that the genetic mechanisms controlling
thymus development are conserved between mouse and human. Our
previous studies have shown that Rhox4 and Plet1 (1600029D21Rik
– Mouse Genome Informatics), specific markers of the mouse third
PP/early thymus primordium, are not expressed in this region during
human thymus organogenesis (Morris et al., 2006; Depreter et al.,
2008). Thus, our data indicate that although the expression patterns
of all genes implicated in thymus organogenesis by functional
studies are conserved between mouse and human, not all gene
expression patterns in this region are conserved between species.
Onset and progression of epithelial cell
differentiation in the human thymic primordium
We next investigated whether patterning of the human thymic
primordium into cortical and medullary compartments occurred in a
similar manner to in the mouse, and at what stage the onset of TEC
differentiation occurred. In the adult mouse thymus, the structural
proteins cytokeratin 8 (K8; Krt8 – Mouse Genome Informatics) and
keratin 5 (K5; Krt5 – Mouse Genome Informatics) are broadly
restricted to cortical TECs (cTECs) and medullary TECs (mTECs),
respectively, and additionally are co-expressed by a minor TEC
population found at the cortico-medullary junction and scattered
throughout the cortex (Klug et al., 1998). These markers are also co-
expressed by most TECs in the E11.5 mouse thymic primordium
(Bennett et al., 2002); by E12.5, high level K5 expression marks a
medullary thymic epithelial progenitor cell population that also
expresses high levels of claudin 4 (Cldn4) and, from ~E13.5, co-stains
with the mTEC marker lectin UEA1 (Hamazaki et al., 2007).
At early week 7 (CS18), K5 and K8 were co-expressed by most,
if not all, TECs in the human thymic primordium, consistent with
the expression pattern seen at the equivalent stage (E11.5) in mouse
(Fig. 3A-A). By mid-week 8 (CS21), these markers had begun to
segregate such that, although most TEC expressed K8, K5 was more
highly expressed by cells along the midline of the thymic lobe and
in some scattered cells (Fig. 3B-B). Expression of EPCAM, a pan-
epithelial marker in the mouse thymus that is expressed at higher
levels in mouse mTECs than cTECs (Farr and Anderson, 1985),
was also similar in the mouse and human thymus. EPCAM was
expressed by all TECs in the week 7 human thymic primordium
(Fig. 3C-C) and by week 15 was expressed strongly by mTECs
and weakly by cTECs (Fig. 3D). These data suggested that the onset
of overt TEC differentiation in human thymus development occurs
around mid-week 8 (CS21), demonstrating that, as in mouse, human
TEC development is initiated after the initiation of FOXN1
expression (Nowell et al., 2011). Consistent with this conclusion,
expression of a functional marker of TEC maturation, major
histocompatibility complex (MHC) Class II (HLA-DR/DP/DQ),
expression of which is Foxn1-dependent in the early mouse thymic
priordium (Nowell et al., 2011), was not detected in human TECs
until mid-week 8 (Fig. 3E-F).
We next determined the pattern of UEA1 staining in human
thymus development, because in the mouse UEA1 binding
identifies mTECs in the thymic primordium from E13.5 (Hamazaki
et al., 2007) and, subsequently, most postnatal mTECs (Farr and
Anderson, 1985). Surprisingly, as no UEA1 staining is observed at
the equivalent stage in the mouse, UEA1 bound most, if not all,
TECs within the week 7 human thymus (Fig. 4A-A). By mid-week
8, UEA1 staining on TEC was restricted to the central area of the
thymic lobes (Fig. 4B-B), suggesting that medullary epithelial
progenitor cells had arisen by mid-week 8, and a subpopulation of
mTECs binding UEA1 at high intensity were present by week 15 of
human fetal development (Fig. 4D-D). Of note is that some non-
epithelial UEA1+ cells were also observed in the human fetal
RESEARCH ARTICLE Development 140 (9)
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thymus, unlike in the mouse. These cells were initially seen lining
week 8 thymic lobes (Fig. 4B-B) and were found throughout the
thymus at week 10 and week 15, possibly indicating UEA1 staining
of vasculature-associated cells (Fig. 4C-D).
We also investigated the expression of CLDN4, as the
Cldn4+UEA1+ population in the fetal mouse thymus contains
progenitors that give rise to Aire+ mTECs (Hamazaki et al., 2007).
By week 8, CLDN4 was expressed by TECs in the central area of
the thymic lobes (Fig. 2I; Fig. 4E-G). These CLDN4+ cells also
expressed MHC class II (HLA-DR/DP/DQ; Fig. 4H-H), suggesting
that, as in the mouse (Hamazaki et al., 2007), these are the first cells
to differentiate into mature medullary TECs. CLDN4 expression
remained restricted to a subpopulation of mTECs and, by week 18,
identified both small clusters of nucleated mTECs and swirls of cells
surrounding an enucleated region that were strongly suggestive of
Hassall’s corpuscles (Fig. 4G-G).
The autoimmune regulator Aire is essential for induction of
central tolerance in mice and humans (Mathis and Benoist, 2009)
and therefore we analyzed AIRE expression during human thymus
development. AIRE+ TECs were not present in the week 10 human
thymic primordium (not shown), but were observed in medullary
areas by week 13 (Fig. 4I-I) and had increased in number by week
17 (Fig. 4J-K).
To investigate differentiation towards the cTEC fate, we
determined the expression pattern of CD205 (LY75 – Human Gene
Nomenclature Database) (Shakib et al., 2009) and CDR2 (Rouse et
al., 1988). CD205 has recently been shown to mark the onset of cTEC
differentiation in the mouse and is expressed as early as E12.5 in
mouse thymus development (Shakib et al., 2009); later in fetal
development, it may mark a common TEPC (Baik et al., 2013).
CDR2 is restricted to cTECs in the human adult thymus (Rouse et
al., 1988). We were unable to detect CD205 or CDR2 expression 
in the early or mid-week 7 thymic primordium by
immunohistochemistry (Fig. 4L-L,N-N). However by mid-week 8,
extensive expression of both markers was observed throughout the
thymic lobes (Fig. 4M-M,O-O). CDR2+ TECs within the mid-week
8 thymus did not express K5, suggesting that they may represent
cortical sub-lineage-restricted epithelial progenitor cells. Again, these
data are consistent with the onset of TEC differentiation occurring
around mid-week 8 in the human thymic primordium.
The chemokine CCL21, which plays a role in hematopoietic
colonization of the thymus in mice (Liu et al., 2006), was detected in
scattered cells in the human thymic primordium at week 11 (Fig. 4P-
P). The number of CCL21+ TECs was substantially increased by
week 17 and appeared to be largely restricted to medullary regions
(Fig. 4Q-Q), consistent with its localization in the mouse (Kwan and
Killeen, 2004). CCL25, a chemokine expressed by mouse TECs in a
Foxn1-dependent manner that also plays a role in hematopoietic
colonization of the thymus (Liu et al., 2006; Nowell et al., 2011), was
first detected at mid-week 8 (Fig. 4R-S). CCL25 expression was
initially detected in scattered cells throughout the human thymic
primordium. By week 17, CCL25 expression was detected only in
cortical TECs (Fig. 4U-W), as shown by co-staining with CDR2 and
EPCAM (Fig. 4V-W), which mark cortical and medullary regions,
respectively, by immunohistochemistry (Farr and Anderson, 1985;
Rouse et al., 1988).
Immigration of mesenchymal cells and
endothelial progenitors into the human thymic
primordium
Neural crest-derived mesenchymal cells form the capsule and
trabeculae of the fetal thymus and also generate the intrathymic
pericytes (Foster et al., 2008). It is well established that thymic
mesenchyme is at least partly responsible for regulating expansion
(Auerbach, 1960; Jenkinson et al., 2003; Anderson et al., 2006) and
migration (Griffith et al., 2009; Foster et al., 2010) of the early
thymic primordium. However, the timing of the initial immigration
of mesenchymal cells into the human thymic primordium has not
been determined. TE7 is a marker of human thymic mesenchymal
cells that has been reported to stain the mesenchymal cells
surrounding the thymic lobes at weeks 7 and 10, and to mark
interlobular fibrous septae, vessels and thymic fibrous capsule at
week 15 (Haynes et al., 1984). At early week 7, we observed cells
stained with TE7 surrounding the thymic primordium, but no
stained cells were seen within the thymic epithelium (Fig. 5A,A).
By mid-week 7, formation of trabeculae was apparent and TE7
expression was also seen in the anterior end of the
thymic/parathyroid primordium, where it appeared to be in the
luminal spaces (Fig. 5B,B). However, mesenchymal cells were not
evident within the thymic epithelium region itself until mid-week 8
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Fig. 3. Onset of TEC differentiation in
the human thymic primordium.
(A-F) Immunohistochemical staining
of thymic primordia at the
developmental stages shown with anti-
Keratin 5 (K5) and anti-Keratin 8 (K8) (A-
B), anti-EPCAM (C-D), or anti-HLA-
DR/DP/DQ (MHC II) and anti-pan-
Cytokeratin (PANK) (E-F). Images are
representative of at least two
independent analyses. Wk, week. Scale
bars: 150 μm in A-C,D-E; 75 μm in 
C,F-F.
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Fig. 4. Expression of markers of cortical and medullary TECs in human thymus development. (A-K) Medullary TEC differentiation. Images show
staining with UEA1 (A-D), anti-CLDN4 (E-G), anti-CLDN4 and anti-HLA-DR/DP/DQ (MHC II) (H-H) and anti-AIRE (I-K). (L-O) Cortical TEC differentiation.
Images show staining with CD205 (L-M) and CDR2 (N-O). (P-W) Chemokine expression. Images show staining with anti-CCL21 (P-Q) and anti-CCL25
(R-W). Developmental stages are as shown. Anti-pan-Cytokeratin (PANK) co-stain reveals the entire thymus primordium. Images are representative of at
least two independent analyses. Wk, week. Scale bars: 150 μm in A-B,D-F,H-H,N-W; 75 μm in C-C; 47.6 μm in G-G; 50 μm in I-I,L-M; 55 μm in J-K. D
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(Fig. 5C,C). At subsequent stages, TE7+ thymic mesenchyme
divided the thymus into discrete lobules, and TE7+ cells were also
present throughout the epithelial regions (Fig. 5D-E) (Haynes et
al., 1984). Thus, the timing of onset of migration of mesenchymal
cells into the human thymic primordium closely follows the onset
of FOXN1 expression (Fig. 2E), consistent with the timing of this
event in the mouse (Foster et al., 2008).
Immigration of vascular progenitors into the mouse thymus is
closely linked to that of neural crest-derived cells, and both of these
processes are Foxn1 dependent (Mori et al., 2010; Nowell et al.,
2011). However, again, the timing of vascular endothelial progenitor
entry into the human thymus has not been determined. Our analysis
identified the presence of CD34hiCD31+ cells in the connective tissue
between the carotid artery and the thymus primordium at mid-week
7 (Fig. 6A-C); occasional cells at this stage were found within the
epithelial component of the primordium (Fig. 6D-D). By late week
7 to mid-week 8, CD34hi cells were found within the thymic lobes
(Fig. 6E-F) and all co-expressed both CD31 (PECAM1 – Human
Gene Nomenclature Database) and VE cadherin (CDH5 – Human
Gene Nomenclature Database), identifying them as endothelial
progenitors (Fig. 6G-G). Of note is that the CD34hi cells present
within the thymic primordium at late week 7 to early week 8 did not
express CD45 (PTPRC – Human Gene Nomenclature Database)
(Fig. 6E-E). Blood vessels per se were present by mid-week 9 (note
long blood vessel-like structures at mid-week 9) (Fig. 6H-I).
Some variation in timing of colonization with endothelial
progenitors was observed: in the thymus primordium from a CS19
fetus (mid to late week 7; 48-51 days old) and a CS20 fetus (late
week 7 to early week 8), several CD34hi cells were present within
the epithelial compartment, and were localized to one discrete
region (Fig. 6D-E). However, in a CS21 fetus (mid to late week 8;
53-54 days old) CD34hi cells were present in the mesenchymal
capsule but were not detected within the epithelial component of
the thymus (Fig. 6F-F). These differences in kinetics of
colonization between different fetal thymi are likely to reflect the
effects of genetic variation within the human population on fetal
thymus development; in this context, it is well established that
thymus organogenesis proceeds at different rates in different inbred
mouse strains.
CD45+CD7+ T-lineage progenitors are first present
at week 8 and lack high level CD34 expression
Hematopoietic colonization of the human fetal thymus has
previously been proposed to occur during early week 8, and the
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Fig. 5. Colonization of the human thymic
primordium by mesenchymal cells. 
(A-E) Images show staining with TE7 at the
developmental stages shown. Anti-pan-
Cytokeratin (PANK) reveals the entire thymus
primordium. Images are representative of at
least two independent analyses. Wk, week.
Scale bars: 150 μm in A-B,D-E; 75 μm in C,C.
Fig. 6. Colonization of the human thymic primordium by vascular endothelial cells. (A-I) Images show staining with anti-CD34 at the
developmental stages shown. Anti-pan-Cytokeratin (PANK) reveals the entire thymus primordium. Anti-CD45 reveals hematopoietic cells. CD31 (G-I)
and VE cadherin (VEcad; I-I) staining reveal vascular endothelial cells. DAPI reveals nuclei. White arrowheads in A-F indicate vascular endothelial cells.
Images are representative of at least two independent analyses. C, carotid artery; Th, thymus; CS, Carnegie stage. Scale bars: 75 μm. D
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week 7 human primordium was reported as being devoid of
hematopoietic cells (Haynes and Heinly, 1995). However, as
acknowledged by the authors, this study was compromised by the
limited material available (Haynes and Heinly, 1995) and, thus,
although the timing at which subsequent stages in T-cell
development are first observed has been determined (Res and Spits,
1999), the stage at which the earliest hematopoietic cells colonize
the human thymus remains unknown. We therefore sought to
determine the kinetics of hematopoietic colonization of the human
thymus using markers associated with human hematopoietic
progenitor cells, including early T-lineage precursors. Of note is that
the earliest T-lineage restricted precursors in human are thought to
RESEARCH ARTICLE Development 140 (9)
Fig. 7. Colonization of the human thymic primordium by hematopoietic cells. (A-M) Images show staining of microdissected human thymic
primordia with anti-CD45, anti-CD34, anti-CD7 and Mac1 as indicated, at the developmental stages shown. Anti-pan-Cytokeratin (PANK) reveals the
entire thymus primordium. Green arrow in B indicates CD45+ cell within the thymic epithelial compartment; white arrows indicate CD45+ cells present
in the perithymic mesenchyme. C,C show detail from boxed regions on mid-week 8 image (C). I-I show boxed area from H-H. Images are
representative of at least two independent analyses. Scale bars: 75 μm in K-M; 150 μm in D. (N-V) Flow cytometric analysis of human thymic primordia
at the developmental stages shown. (N-U) Plots show staining with anti-CD45 and anti-CD34 and anti-CD7 after gating on live cells (i.e. against DAPI).
Q,S,U show cells after gating on CD45+ cells (P,R,T). Boxes on O,Q,S,U at each age indicate CD34hi, CD34int and CD34lo/neg cells. (N-U) n=1 for each age
shown. (V) Plot shows staining with markers for plasmacytoid (CD123+BDCA2+) dendritic cells after gating on CD45+CD19–CD3– cells and is
representative of at least two independent analyses. SSC, side scatter; Wk, week. See also supplementary material Table S2.
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be bone marrow-derived CD45+CD34hiCD7+ cells based on
functional analysis of hematopoietic cells at week 8-9 of fetal
development, the earliest time-point examined (Haddad et al.,
2006).
We observed CD45+ hematopoietic cells in the perithymic space
at early week 7 (Fig. 7A,A), and by early to mid-week 7 we
detected occasional CD45+ cells within the thymic primordium of
some embryos (Fig. 7B,B, green arrow). By early to mid-week 8,
CD45+ cells lined the perithymic space and were also distributed
throughout the thymic lobes, and by week 10 the numbers of CD45+
cells within the thymus had increased dramatically (Fig. 7C,D).
However, no CD34hiCD45+ cells could be detected prior to week 9
(Fig. 7E-M). Co-staining with additional markers indicated that at
mid-week 8 a proportion of the CD45+ cells were Mac1 (IGTAM)+
macrophages (Fig. 7F-F). Of note is that comparison of
immunohistochemistry and flow cytometric staining data indicated
that only cells expressing high levels of CD34 were detected by
immunohistochemistry.
Surprisingly, given the absence of CD34hiCD45+ cells at this
stage, CD45+CD7+ cells were observed within the thymic lobes
from early week 8, when they comprised a minor subpopulation of
intrathymic CD45+ cells (Fig. 7G-I; CD45+CD7+Mac1–;
CD45+CD7–Mac1+ and CD45+CD7–Mac1– cells were all present at
this stage). Consistent with previous reports that CD7 identifies
extra-thymic hematopoietic precursor cells with T-lineage potential
(Haynes and Heinly, 1995; Haynes et al., 2000), we observed some
CD7int cells located in the perithymic space. These cells were
sometimes juxtaposed to CD7hi cells that appeared to be actively
entering the thymus, suggesting that CD7 upregulation might occur
upon migration into the thymic epithelium (Fig. 7H-I). However,
intrathymic CD34hiCD7hi cells were not detected until mid-week 9,
when they were observed closely associated with the blood vessels
(Fig. 7K-U). Most intra-thymic CD7+ cells at early week 8 were
CD34int, consistent with the presence of CD34int cells in the fetal
liver (FL) (Fig. 7P,Q). A minor population of CD34lo/negCD7+ cells
were also present at week 8, which might represent the
CD34negCD7+CD56+ natural killer (NK) cell population previously
described in the FL (Phillips et al., 1992; Bárcena et al., 1993).
However, the week 8 hematopoietic population contained T-cell
precursors, as culture of week 8 thymic lobes microdissected free of
any other tissues resulted in a robust expansion of CD45+
thymocytes (supplementary material Fig. S1). Furthermore,
expression of c-Kit (KIT – Human Gene Nomenclature Database),
IL7R, pre Tα (PTCRA – Human Gene Nomenclature Database),
RAG1, CD3δ (CD3D – Human Gene Nomenclature Database), and
TCR β and γ (TRB and TRG – Human Gene Nomenclature
Database) constant region mRNA was detected in microarray
analysis of whole mid-week 8 fetal human thymic lobes
(supplementary material Table S2). Collectively, these data pinpoint
the stage of human thymus development at which colonization by
hematopoietic progenitors occurs, and identify a novel
subpopulation of CD34intCD7+ cells that might represent
intrathymic T lineage-restricted progenitors.
Subsequent analyses confirmed previous studies indicating the
appearance of CD4 and CD8 single positive and γδ TCR+
thymocytes, and CD4+CD25+ T regulatory cells in the human fetal
thymus by week 15 (Lobach and Haynes, 1987; Galy et al., 1993;
Haynes and Heinly, 1995; Cupedo et al., 2005) (data not shown).
Low numbers of conventional dendritic cells (cDCs) were detected
at week 15, consistent with a previous report indicating their
presence at week 12 (Janossy et al., 1986). CD11c+CD11b+ cDCs
increased proportionally by week 16 (not shown), together with a
numerical increase in the entire cDC population. Of note is that
plasmacytoid dendritic cells were already evident at week 15
(Fig. 7V).
DISCUSSION
The data presented above address the current profound gap in
understanding of human thymus development. Collectively, they
demonstrate that the principal genetic mechanisms currently known
to regulate thymus organogenesis in the mouse are conserved in
humans, and that key cellular processes, including the
developmental origin of the thymus in the third pharyngeal pouches,
are also conserved. They establish that overt differentiation of
cortical and medullary TECs occurs from mid-week 8 in the human
thymic primordium and closely mirrors the progression seen in
mouse in terms of phenotypic and functional marker expression,
and that colonization of the human thymic primordium by
endothelial and mesenchymal cells occurs from early and mid-week
8, respectively. Finally, they define the timing of onset of
hematopoietic cell colonization of the human thymic primordium
and reveal, in contrast to expectations from previous studies, that
the first colonizing hematopoietic cells that express T lineage
affiliated markers are CD45+CD7+CD34int cells, which are present
from early week 8. These findings are summarized in
supplementary material Table S3.
Conservation of mechanisms of thymus
organogenesis between mouse and human
The mouse is the principal model organism used to determine
regulatory mechanisms operating to control thymus development
and function, and therefore interrogation of its utility for predicting
mechanisms that control these processes in the human is essential.
The data presented above establish that the spatial and temporal
expression pattern of all of the genes tested, which have been
demonstrated by genetic analyses to have functional roles in thymus
development, are conserved between mouse and human. They
therefore validate the mouse as a model for understanding human
thymus organogenesis. Of note is that although some variation in
expression between mouse and human was observed in the genes
analyzed herein, this did not affect expression in the thymus
domain; for instance, PAX9 is expressed throughout the pharyngeal
pouches in mouse but was detected only in pouches 3 and 4 in
human. However, it is of interest that two genes, RHOX4 and
PLET1, expression of which in mouse is restricted to the pharyngeal
endoderm and the thymus domain of the third pharyngeal pouch,
respectively, at this developmental stage, are not expressed in the
human pharyngeal pouches or thymic rudiment, indicating that not
all gene expression patterns are conserved. In this regard, we note
that neither of these genes has been shown to be important for
thymus organogenesis by functional studies and, indeed, both are
currently of unknown function.
Differentiation of the earliest progenitor cells in
the human thymic primordium
The data presented above demonstrate that overt differentiation of
cortical and medullary TEC occurs at around mid-week 8. However,
the thymic rudiment itself is present from early week 6 and
therefore, our data further indicate that the week 6 and week 7
thymic primordia consist mainly of undifferentiated TECs. Thus,
cell surface markers expressed by most TECs at these
developmental stages will be useful for isolating and characterizing
the differentiative potential of early progenitor TECs. Similarly, the
expression patterns demonstrated here for CD205 and CLDN4 are
2023RESEARCH ARTICLEHuman thymus development
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consistent with these markers identifying early medullary and
cortical sub-lineage-restricted progenitors in the human, as well as
mouse, thymus. Collectively, these data pave the way for
prospective isolation and functional testing of defined human fetal
TEC subpopulations, which will be essential if progress is to be
made in defining conditions for in vitro propagation of human
TEPCs or for generating these cells from embryonic stem cells for
use in cell replacement therapies.
We note that FOXN1, a master regulator of TEC differentiation,
is expressed in the human thymic primordia from mid-week 6. In
the mouse, high-level Foxn1 expression is initiated at E11.5 and the
onset of overt TEC differentiation closely follows this upregulation.
The interval between upregulation of FOXN1 and the appearance of
differentiating cTECs and mTECs is therefore much longer in
human than in mouse. This probably reflects differences in cell
cycle; however, it is also possible that other, as yet unknown
mechanisms, limiting the time of onset of TEC differentiation are
initiated or repressed with different kinetics to FOXN1 in the
human.
Kinetics of initial mesenchymal and vascular
endothelial cell entry into the human thymus
Our data indicate that entry of vascular endothelial progenitor cells
into the human thymus occurs as early to mid-week 8, with
migrating cells observed in the connective tissue between the carotid
artery and the thymus from early to mid-week 7. They further show
that, although formation of trabeculae is observed from mid-week
7, the time of entry of neural crest-derived mesenchymal cells into
the epithelial regions of the thymus is mid-week 8. These processes
are thus closely linked, as in the mouse. Notably, both events occur
after initiation of high-level FOXN1 expression in the human
thymus, consistent with the demonstration in mouse that thymic
colonization with both mesenchymal and vascular endothelial cells
is Foxn1 dependent. However, our data further suggest that entry
of vascular endothelial progenitors into the epithelial region of the
thymic primordium precedes its colonization with mesenchymal
cells, in contrast to the widespread assumption that immigration of
vascular endothelial cells follows that of neural crest-derived
mesenchyme.
Identity of the first thymus-seeding
hematopoietic cells
The data presented in Fig. 7 establish that hematopoietic cell
colonization of the human thymus primordium occurs from early
to mid-week 7. As in mouse, hematopoietic colonization of the
thymus therefore closely follows upregulation of high level FOXN1
expression, consistent with FOXN1-regulation of CCL25 and
DLL4, which are required for migration and T lineage commitment
of thymus seeding progenitors, respectively (Liu et al., 2006;
Hozumi et al., 2008; Koch et al., 2008).
The earliest human thymus seeding T lineage-restricted
progenitors have previously been proposed to be
CD45+CD34hiCD7+ cells, based on functional analysis of
hematopoietic cells in the week 8-9 fetal thymus (Galy et al., 1993;
Haynes and Heinly, 1995; Haddad et al., 2006). Our data indicate
that the hematopoietic population of the early human fetal thymus
is heterogeneous, and that all intrathymic hematopoietic cells are
CD34int/– until early to mid-week 9. Indeed, the first colonizing
hematopoietic cells appearing at early week 7 are
CD45+CD34–CD7–, and some CD45+ at least as early as early week
8 are Mac1+ macrophages. Intrathymic CD45+CD34intCD7+ and
CD45+CD34lo/–CD7+ cells are present from early week 8; this was
surprising, because the earliest intrathymic T-lineage progenitors
were expected to express CD34 (Galy et al., 1993; Haynes and
Heinly, 1995; Haddad et al., 2006). Although we cannot exclude
the possibility that these cells mature within the thymic primordium
to generate CD45+CD34hiCD7+ cells, we note that
CD45+CD34hiCD7+ cells first appear within the thymus at mid-
week 9 coincident with establishment of blood vessels, and
furthermore that cells of this phenotype are initially found closely
associated with blood vessels. However, the thymus contains T-
lineage progenitors at least as early as week 8, as evidenced by the
robust development of thymocytes in fetal thymic organ cultures
established at this developmental stage and the intrathymic
expression of genes associated with early human thymocyte
development. Thus, we favor the idea that the thymus-seeding
population changes once the vasculature has been established as the
primary route of entry, and comprises CD45+CD34hiCD7+ cells only
after this point.
CD45+CD34lo/–CD7+ cells have been described previously in the
FL; these are NK cells, and also express CD56 (NCAM1 – Human
Gene Nomenclature Database) (Phillips et al., 1992; Bárcena et al.,
1993). Thus, the minor CD45+CD34lo/–CD7+ population present at
week 8 might also be NK cells. The CD45+CD34intCD7+ population
present in the pre-vascular thymus is, however, a novel intrathymic
hematopoietic population that is probably T lineage committed
based on its expression of CD7. In this regard, it is of interest that
CD7hi cells were never detected in the connective tissue associated
with the pre-vascular thymus or in the perithymic space, but were
sometimes observed interspersed with thymic epithelial cells
adjacent to the mesenchymal capsule, suggesting that in the pre-
vascular thymus, upregulation of CD7 might occur upon contact
with thymic epithelial cells. Of note is that the FL contains a
population of CD45+CD34int CD7– cells (Haddad et al., 2006) that
might constitute precursors for this population. Based on these data,
we therefore suggest that the pre-vascular thymus is initially seeded
by CD45+CD34intCD7– cells and that upregulation of CD7 in these
cells occurs dynamically as part of the thymus-seeding process. We
further suggest that this population is superseded by the previously
described T lineage-restricted CD45+CD34hiCD7+ population
(Haddad et al., 2006) only following establishment of the thymic
vasculature.
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